Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase II study of FIL ONLUS

Detalles Bibliográficos
Autores principales: Stefoni, Vittorio, Marangon, Miriam, Re, Alessandro, Lleshi, Arben, Bonfichi, Maurizio, Pinto, Antonello, Bianchetti, Nicola, Pellegrini, Cinzia, Argnani, Lisa, Zinzani, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556670/
https://www.ncbi.nlm.nih.gov/pubmed/33054094
http://dx.doi.org/10.3324/haematol.2019.243170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556670/
https://www.ncbi.nlm.nih.gov/pubmed/33054094
http://dx.doi.org/10.3324/haematol.2019.243170

Ejemplares similares